Multi-Organ metabolic profiling with [18F]F-FDG PET/CT predicts pathological response to neoadjuvant immunochemotherapy in resectable NSCLC.

Purpose: To develop and validate a novel nomogram combining multi-organ PET metabolic metrics for major pathological response (MPR) prediction in resectable non-small cell lung cancer (rNSCLC) patients receiving neoadjuvant immunochemotherapy. Methods: This retrospective cohort included rNSCLC patie...

Full description

Bibliographic Details

Published in:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 53; no. 1; pp. 128 - 142
Main Authors:	Ma, Qiaoke, Yang, Jinhui, Guo, Xuan, Mu, Wenna, Tang, Yongxiang, Li, Jian, Hu, Shuo
Format:	Journal Article
Published:	Springer Nature Dec2025
Online Access:	View this record in EBSCOhost